Discontinued — last reported Q3 '19
Boston Scientific Operating Lease Liabilities increased by 1.1% to $445.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 19.3%, from $373.00M to $445.00M. Over 4 years (FY 2020 to FY 2024), Operating Lease Liabilities shows relatively stable performance with a 0.0% CAGR.
An increase reflects long-term expansion of the leased asset base, while a decrease indicates a reduction in long-term lease commitments.
This represents the portion of operating lease obligations that are due beyond the next twelve months. It reflects the l...
Standard long-term liability for companies with significant real estate or equipment footprints.
operating_lease_liabilities_non_current| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $359.00M | $377.00M | $389.00M | $378.00M | $357.00M | $350.00M | $347.00M | $360.00M | $401.00M | $400.00M | $390.00M | $382.00M | $365.00M | $373.00M | $401.00M | $399.00M | $440.00M | $445.00M |
| QoQ Change | — | +5.0% | +3.2% | -2.8% | -5.6% | -2.0% | -0.9% | +3.7% | +11.4% | -0.2% | -2.5% | -2.1% | -4.5% | +2.2% | +7.5% | -0.5% | +10.3% | +1.1% |
| YoY Change | — | — | — | — | -0.6% | -7.2% | -10.8% | -4.8% | +12.3% | +14.3% | +12.4% | +6.1% | -9.0% | -6.8% | +2.8% | +4.5% | +20.5% | +19.3% |